Operating Lease, Right-of-Use Asset of CORCEPT THERAPEUTICS INC from 31 Jan 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
CORCEPT THERAPEUTICS INC quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Jan 2019 to 30 Sep 2025.
  • CORCEPT THERAPEUTICS INC Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $4,776,000, a 13% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

CORCEPT THERAPEUTICS INC Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $4,776,000 -$727,000 -13% 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $4,964,000 -$720,000 -13% 30 Jun 2025 10-Q 31 Jul 2025 2025 Q2
Q1 2025 $5,147,000 +$5,086,000 +8338% 31 Mar 2025 10-Q 05 May 2025 2025 Q1
Q4 2024 $5,324,000 +$5,204,000 +4337% 31 Dec 2024 10-Q 04 Nov 2025 2025 Q3
Q3 2024 $5,503,000 +$5,325,000 +2992% 30 Sep 2024 10-Q 30 Oct 2024 2024 Q3
Q2 2024 $5,684,000 +$5,449,000 +2319% 30 Jun 2024 10-Q 29 Jul 2024 2024 Q2
Q1 2024 $61,000 -$514,000 -89% 31 Mar 2024 10-Q 01 May 2024 2024 Q1
Q4 2023 $120,000 -$1,023,000 -90% 31 Dec 2023 10-K 26 Feb 2025 2024 FY
Q3 2023 $178,000 -$1,529,000 -90% 30 Sep 2023 10-Q 01 Nov 2023 2023 Q3
Q2 2023 $235,000 -$2,029,000 -90% 30 Jun 2023 10-Q 02 Aug 2023 2023 Q2
Q1 2023 $575,000 -$2,225,000 -79% 31 Mar 2023 10-Q 03 May 2023 2023 Q1
Q4 2022 $1,143,000 +$629,000 +122% 31 Dec 2022 10-K 15 Feb 2024 2023 FY
Q3 2022 $1,707,000 +$685,000 +67% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $2,264,000 +$740,000 +49% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 $2,800,000 +$780,000 +39% 31 Mar 2022 10-Q 03 Nov 2022 2022 Q3
Q4 2021 $514,000 -$1,995,000 -80% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 $1,022,000 -$1,971,000 -66% 30 Sep 2021 10-Q 03 Nov 2021 2021 Q3
Q2 2021 $1,524,000 -$1,948,000 -56% 30 Jun 2021 10-Q 29 Jul 2021 2021 Q2
Q1 2021 $2,020,000 -$1,062,000 -34% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $2,509,000 -$937,000 -27% 31 Dec 2020 10-K 15 Feb 2022 2021 FY
Q3 2020 $2,993,000 +$2,251,000 +303% 30 Sep 2020 10-Q 03 Nov 2020 2020 Q3
Q2 2020 $3,472,000 +$2,366,000 +214% 30 Jun 2020 10-Q 04 Aug 2020 2020 Q2
Q1 2020 $3,082,000 +$1,617,000 +110% 31 Mar 2020 10-Q 04 May 2020 2020 Q1
Q4 2019 $3,446,000 +$646,000 +23% 31 Dec 2019 10-K 23 Feb 2021 2020 FY
Q3 2019 $742,000 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 $1,106,000 30 Jun 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 $1,465,000 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 $2,800,000 31 Jan 2019 10-Q 05 May 2022 2022 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.